Evidence map›Paper›PMID 31077162›Full record

ArticleBMC cancer2019

Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis.

Diama Bhadra Vale, Cassio Cardoso Filho, Julia Yoriko Shinzato, Fernanda Servidoni Spreafico, Partha Basu, Luiz Carlos Zeferino

Abstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Precision screening for esophageal squamous cell carcinoma in China.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Diama Bhadra ValeObstetrics and Gynecology Department, School of Medical Sciences of Unicamp, Rua Alexander Fleming 101, Campinas, 13083-790, Brazil. dvale@unicamp.br.ORCID http://orcid.org/0000-0003-2423-0225
Cassio Cardoso FilhoObstetrics and Gynecology Department, School of Medical Sciences of Unicamp, Rua Alexander Fleming 101, Campinas, 13083-790, Brazil.
Julia Yoriko ShinzatoObstetrics and Gynecology Department, School of Medical Sciences of Unicamp, Rua Alexander Fleming 101, Campinas, 13083-790, Brazil.
Fernanda Servidoni SpreaficoObstetrics and Gynecology Department, School of Medical Sciences of Unicamp, Rua Alexander Fleming 101, Campinas, 13083-790, Brazil.
Partha BasuInternational Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, France.
Luiz Carlos ZeferinoObstetrics and Gynecology Department, School of Medical Sciences of Unicamp, Rua Alexander Fleming 101, Campinas, 13083-790, Brazil.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundBreast cancer is the most common female cancer in Brazil with an estimated 60 thousand new cases per year. Widespread use of mammography opportunistic screening has been observed in the last 20 years, including women under 50 years old. The present study aimed to analyse the trends in breast cancer stage distribution at diagnosis as a function of age in the study period.

methodsThis paper examined temporal trends of stage distribution in women with breast cancer diagnosed between 2000 and 2015 in São Paulo state, Brazil. Data from the Hospital Cancer Registry of the region were utilized. Completeness was high. The sample was described according to age, stage and date of diagnosis using absolute frequency and proportions (%). For trends, the Cochran-Armitage test was used with a 5% level of significance (P-value< 0.05).

resultsA total of 93,674 women were included in the analysis with a median age of 56 years old. One-third (34.4%) of the women were younger than 50 years old, and stage II was the most frequent stage (36.4%), even when analysed by age groups. Stage 0 corresponded to 7.7% (7247 women) of cases. In the study period, there was a significant trend towards an increase in Stages 0, I and IV (P < 0.01) and a trend towards a decrease in Stages IIA, IIB and IIIB (P < 0.001). Stage IIA was more prevalent until 2009, and stage I was more prevalent thereafter. The trends to increase the proportion of Stages 0 and I and to decrease the proportion of stages IIA, IIB and IIIB were significant in all age groups.

conclusionsBreast cancer cases are diagnosed mainly at early stages, and approximately one-third of cases are younger than 50 years old. Downstaging has been shown. Opportunistic screening may have supported these results. Further studies are needed to show whether these results will impact the prognosis.

Indexed as

AdultAgedAge DistributionBrazilBreast NeoplasmsEarly Detection of CancerFemaleHumansMammographyMass ScreeningMiddle AgedNeoplasm StagingSpatio-Temporal AnalysisYoung AdultBreast NeoplasmsEarly Detection of CancerEpidemiologic StudiesNeoplasm Staging

Identifiers

PMID31077162
PMCPMC6509851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.